Health ministry issues draft amendment to ND&CT Rules for deemed approval of clinical trials
By, Admin1 min read
Share
Merck, known as MSD outside the United States and Canada, announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Merck
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
